Cost-effectiveness of Watchman device

Long-term analysis shows cost-effectiveness of WATCHMAN left atrial appendage closure device over warfarin and NOACs in reducing stroke risk in non-valvular atrial fibrillation patients.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1V8TfHi
Publié par à
Libellés :

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)